Veena Shankaran, MD, MS
GI cancers are a diverse group of life-threatening diseases; collectively they’re the most common form of cancer in the United States. While significant advances have been made in the way these diseases are treated, there is still room for improvement. I’m passionate about identifying new therapies for GI cancers and increasing the number of clinical trials available. Cancers affecting the gut can also have a major impact on a person’s quality of life — making it difficult for them to enjoy a meal with friends and family. I find it rewarding to help people live not only longer, but better, and participate in the aspects life that give it meaning, like eating and socializing.
I believe in providing you and your family with the resources to navigate your illness and treatment course with self-assurance and dignity. I enjoy getting to know my patients, explaining what the latest science has to say and discussing what clinical trials are available. There’s been a lot of progress in GI cancer therapy in recent years, and I look forward to sharing that information with you. We’ll work together to develop a treatment plan that is based on the evidence as well as your particular needs and circumstances.
Specialty: Medical Oncology
I am a board-certified medical oncologist who specializes in GI malignancies. My primary clinical interest is in cancers of the stomach and esophagus; however, I care for patients with a variety of tumors affecting the digestive system. At SCCA, I am also working with colleagues to increase access to novel treatment options by expanding the GI cancer clinical trial program.
In addition to working with patients, I am the co-director of the Hutchinson Institute for Cancer Outcomes Research. Based at Fred Hutch, this research institute studies health care economics and policy. My research focuses on the out-of-pocket costs that patients with GI cancers experience as well as the cost-effectiveness of cancer therapy; I study how to deliver great care without wasting resources. As a national leader in financial toxicity research, I currently lead the largest prospective cooperative group study to assess financial outcomes for patients with cancer through the SWOG Cancer Research Network. In addition, I serve on SWOG’s Cancer Care Delivery Research Committee.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.
SCCA's Veena Shankaran, MD, was interviewed by The ASCO Post about her ASCO Quality Care Symposium presentation on findings from a study on financial hardships among patients with metastatic colorectal cancer.
SCCA's Veena Shankaran, MD, was interviewed by The Evidence Base discussing her ASCO 2020 virtual presentation on financial hardships among colon cancer patients.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.